Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08GQK
|
||||
Former ID |
DIB010177
|
||||
Drug Name |
WS-75624B
|
||||
Indication | Cardiovascular disorder [ICD10:I00-I99] | Terminated | [546199] | ||
Company |
Fujisawa Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c2nc(sc2)CCCCCC(O)C)nc(cc(c1OC)OC)C(=O)O
|
||||
CAS Number |
CAS 157242-75-6
|
||||
Target and Pathway | |||||
Target(s) | Endothelin converting enzyme | Target Info | Modulator | [531869], [533597] | |
References | |||||
Ref 531869 | The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sci. 2012 Oct 15;91(13-14):743-8. | ||||
Ref 533597 | WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. II. Structure elucidation of WS75624 A and B. J Antibiot (Tokyo). 1995 Oct;48(10):1073-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.